Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2017 (2017), Article ID 2397429, 9 pages
https://doi.org/10.1155/2017/2397429
Research Article

Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments

1Department of Medicine, Dalhousie University, Halifax, NS, Canada
2The Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta and The Provincial Laboratory for Public Health, Edmonton, AB, Canada
3Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
4School of Public Health, University of Alberta, Edmonton, AB, Canada

Correspondence should be addressed to T. J. Marrie

Received 6 January 2017; Revised 23 February 2017; Accepted 5 March 2017; Published 23 March 2017

Academic Editor: R. Andrew Mcivor

Copyright © 2017 T. J. Marrie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Heffron, “The pneumococcus and type incidence in pneumonia,” in Pneumonia by R. Heffron, Introduction by Maxwell Finland. The Biology of Pneumococcus by B. White, New Foreword by Robert Austin, R. Heffron, Ed., pp. 18–89, Harvard University Press, Cambridge, Mass, USA, Second Printing, 1979.
  2. C. Rodrigo and W. S. Lim, “The relevance of pneumococcal serotypes,” Current Infectious Disease Reports, vol. 16, no. 4, pp. 403–411, 2014. View at Publisher · View at Google Scholar
  3. I. Yildirim, K. M. Shea, and S. I. Pelton, “Pneumococcal disease in the era of pneumococcal conjugate vaccine,” Infectious Disease Clinics of North America, vol. 29, no. 4, pp. 679–697, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. M. R. Griffin, Y. Zhu, M. R. Moore, C. G. Whitney, and C. G. Grijalva, “U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination,” New England Journal of Medicine, vol. 369, no. 2, pp. 155–163, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Luján, J. Burgos, M. Gallego et al., “Effects of immunocompromise and comorbidities on pneumococcal serotypes causing invasive respiratory infection in adults: implications for vaccine strategies,” Clinical Infectious Diseases, vol. 57, no. 12, pp. 1722–1730, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Rudnick, Z. Liu, A. Shigayeva et al., “Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995–2011,” Vaccine, vol. 31, no. 49, pp. 5863–5871, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. B. Harboe, J. Dalby, D. M. Weinberger et al., “Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease—incidence and mortality,” Clinical Infectious Diseases, vol. 59, pp. 1066–1073, 2014. View at Google Scholar
  8. Canada Communicable Disease Report, “Case definitions for diseases under national surveillance,” Health Canada, vol. 26, supplement 3, article 51, 2000. View at Google Scholar
  9. R. R. Facklam and A. Washington J, “Streptococcus and related catalase-negative gram-positive cocci,” in Manual of Clinical Microbiology, A. Balows, W. J. Hausler Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy, Eds., pp. 238–257, American Society for Microbiology, Washington, DC, USA, 5th edition, 1991. View at Google Scholar
  10. “Surveillance and reporting,” http://www.ahw.gov.ab.ca/IHDA_Retrieval.
  11. http://work.alberta.ca/labour/industry-profiles.html.
  12. A. St. Maurice, W. Schaffner, M. R. Griffin, N. Halasa, and C. G. Grijalva, “Persistent sex disparities in invasive pneumococcal diseases in the conjugate vaccine era,” Journal of Infectious Diseases, vol. 214, no. 5, pp. 792–797, 2016. View at Publisher · View at Google Scholar
  13. T. J. Marrie and L. Wu, “Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU,” Chest, vol. 127, no. 4, pp. 1260–1270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Segal, D. Greenberg, R. Dagan, and S. Ben-Shimol, “Disparities in PCV impact between different ethnic populations cohabiting in the same region: a systematic review of the literature,” Vaccine, vol. 34, no. 37, pp. 4371–4377, 2016. View at Publisher · View at Google Scholar
  15. T. J. Marrie and J. Q. Huang, “Epidemiology of community-acquired pneumonia in Edmonton, Alberta: an emergency department-based study,” Canadian Respiratory Journal, vol. 12, no. 3, pp. 139–142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. R. Moore, R. Link-Gelles, W. Schaffner et al., “Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance,” The Lancet Infectious Diseases, vol. 15, no. 3, pp. 301–309, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Desai, M. E. Policarpio, K. Wong, J. Gubbay, J. Fediurek, and S. Deeks, “The epidemiology of invasive pneumococcal disease in older adults from 2007 to 2014 in Ontario, Canada: a population-based study,” CMAJ Open, vol. 4, no. 3, pp. E545–E550, 2016. View at Publisher · View at Google Scholar
  18. J. Q. Huang, P. M. Hooper, and T. J. Marrie, “Factors associated with length of stay in hospital for suspected community-acquired pneumonia,” Canadian Respiratory Journal, vol. 13, no. 6, pp. 317–324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Plevneshi, T. Svoboda, I. Armstrong et al., “Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto,” PLoS ONE, vol. 4, no. 9, Article ID e7255, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Mercat, J. Nguyen, and B. Dautzenberg, “An outbreak of pneumococcal pneumonia in two men's shelters,” Chest, vol. 99, no. 1, pp. 147–151, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. G. J. Tyrrell, M. Lovgren, Q. Ibrahim et al., “Epidemic of invasive pneumococcal disease, Western Canada, 2005–2009,” Emerging Infectious Diseases, vol. 18, no. 5, pp. 733–740, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. Framework for a healthy Alberta, http://www.health.alberta.ca/documents/Framework-For-Health-2003.pdf.
  23. J. P. Nuorti, J. C. Butler, M. M. Farley et al., “Cigarette smoking and invasive pneumococcal disease,” New England Journal of Medicine, vol. 342, no. 10, pp. 681–689, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. L. A. Burman, R. Norrby, and B. Trollfors, “Invasive pneumococcal infections: incidence, predisposing factors, and prognosis,” Reviews of Infectious Diseases, vol. 7, no. 2, pp. 133–142, 1985. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Fernández-Solá, A. Junque, and R. Estruch, “High alcohol intake as a risk and prognostic factor for community-acquired pneumonia,” Archives of Internal Medicine, vol. 155, no. 15, pp. 1649–1654, 1995. View at Publisher · View at Google Scholar
  26. A. De Roux, M. Cavalcanti, M. A. Marcos et al., “Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia,” Chest, vol. 129, no. 5, pp. 1219–1225, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Saitz, W. A. Ghali, and M. A. Moskowitz, “The impact of alcohol-related diagnoses on pneumonia outcomes,” Archives of Internal Medicine, vol. 157, no. 13, pp. 1446–1452, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Wong, T. J. Marrie, S. Garg, J. D. Kellner, and G. J. Tyrrell, “Welders are at increased risk for invasive pneumococcal disease,” International Journal of Infectious Diseases, vol. 14, no. 9, pp. e796–e799, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Curcio, A. Cané, and R. Isturiz, “Redefining risk categories for pneumococcal disease in adults: critical analysis of the evidence,” International Journal of Infectious Diseases, vol. 37, pp. 30–35, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Shigayeva, W. Rudnick, K. Green et al., “Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs,” Clinical Infectious Diseases, vol. 62, no. 2, pp. 139–147, 2015. View at Publisher · View at Google Scholar
  31. A. Wong, T. J. Marrie, S. Garg, J. D. Kellner, and G. J. Tyrrell, “Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies,” Epidemiology and Infection, vol. 138, no. 12, pp. 1804–1810, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. C. G. Whitney, M. Moore, T. Pilishvill et al., “Use of 13 valent pneumococcal vaccine and 23 valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on immunization practices,” Morbidity and Mortality Weekly Report (MMWR), vol. 61, no. 40, pp. 816–819, 2012. View at Google Scholar
  33. R. C. Tilghman and M. Finland, “Clinical significance of bacteremia in pneumococcic pneumonia,” Archives of Internal Medicine, vol. 59, no. 4, pp. 602–619, 1937. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Austriam and J. Gold, “Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia,” Annals of internal medicine, vol. 60, pp. 759–776, 1964. View at Publisher · View at Google Scholar · View at Scopus
  35. V. L. Yu, C. C. C. Chiou, C. Feldman et al., “An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome,” Clinical Infectious Diseases, vol. 37, no. 2, pp. 230–237, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. F. G. Zampieri, M. Park, F. S. Machado, and L. C. P. Azevedo, “Sepsis-associated encephalopathy: not just delirium,” Clinics, vol. 66, no. 10, pp. 1825–1831, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Hosokawa, N. Gaspard, F. Su, M. Oddo, J.-L. Vincent, and F. S. I. Taccone, “Clinical neurophysiological assessment of sepsis-associated brain dysfunction: a systematic review,” Critical Care, vol. 18, no. 6, article 674, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. L. A. Eidelman, D. Putterman, C. Putterman, and C. L. Sprung, “The spectrum of septic encephalopathy: definitions, etioloqies, and mortalities,” Journal of the American Medical Association, vol. 275, no. 6, pp. 470–473, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Cumbler, “In-hospital ischemic stroke,” The Neurohospitalist, vol. 5, no. 3, pp. 173–181, 2015. View at Publisher · View at Google Scholar
  40. V. Guiraud, M. B. Amor, J.-L. Mas, and E. Touzé, “Triggers of ischemic stroke: a systematic review,” Stroke, vol. 41, no. 11, pp. 2669–2677, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. M. S. V. Elkind, C. L. Carty, E. S. O'Meara et al., “Hospitalization for infection and risk of acute ischemic stroke: the Cardiovascular Health Study,” Stroke, vol. 42, no. 7, pp. 1851–1856, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. Y.-G. Chen, T.-Y. Lin, W.-Y. Huang, C.-L. Lin, M.-S. Dai, and C.-H. Kao, “Association between pneumococcal pneumonia and venous thromboembolism in hospitalized patients: a nationwide population-based study,” Respirology, vol. 20, no. 5, pp. 799–804, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. P. D. Stein, A. Beemath, F. Matta et al., “Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II,” American Journal of Medicine, vol. 120, no. 10, pp. 871–879, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. V. F. Tapson, “Acute pulmonary embolism,” New England Journal of Medicine, vol. 358, no. 10, pp. 1037–1052, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Barbar, F. Noventa, V. Rossetto et al., “A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score,” Journal of Thrombosis and Haemostasis, vol. 8, no. 11, pp. 2450–2457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. R. Kahn, W. Lim, A. S. Dunn et al., “Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest, vol. 141, no. 2, supplement, pp. e195S–e226S, 2012. View at Publisher · View at Google Scholar
  47. R. E. Greene, “The radiology of pulmonary infection,” in Fishman's Pulmonary Diseases and Disorders, A. P. Fishman, J. A. Elias, J. A. Fishman, M. A. Grippi, R. M. Senior, and A. I. Pack, Eds., chapter 113, pp. 2017–2029, McGraw-Hill, New York, NY, USA, 4th edition, 2008. View at Google Scholar
  48. A. Pande, S. Nasir, A. M. Rueda et al., “The incidence of necrotizing changes in adults with pneumococcal pneumonia,” Clinical Infectious Diseases, vol. 54, no. 1, pp. 10–16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Dawar, B. Russell, K. McClean, P. N. Levett, G. J. Tyrrell, and J. Irvine, “A case of necrotizing fasciitis due to Streptococcus pneumoniae serotype 5 in Saskatchewan,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 19, no. 1, pp. 69–71, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Saraceni and D. Schwed-Lustgarten, “Pneumococcal sepsis-induced purpura fulminans in an asplenic adult patient without disseminated intravascular coagulation,” American Journal of the Medical Sciences, vol. 346, no. 6, pp. 514–516, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. C. T. Carpenter and A. B. Kaiser, “Purpura fulminans in pneumococcal sepsis: case report and review,” Scandinavian Journal of Infectious Diseases, vol. 29, no. 5, pp. 479–483, 1997. View at Publisher · View at Google Scholar · View at Scopus
  52. D. M. Musher, A. M. Rueda, A. S. Kaka, and S. M. Mapara, “The association between pneumococcal pneumonia and acute cardiac events,” Clinical Infectious Diseases, vol. 45, no. 2, pp. 158–165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Ramirez, S. Aliberti, M. Mirsaeidi et al., “Acute myocardial infarction in hospitalized patients with community-acquired pneumonia,” Clinical Infectious Diseases, vol. 47, no. 2, pp. 182–187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Soto-Gomez, A. Anzueto, G. W. Waterer, M. I. Restrepo, and E. M. Mortensen, “Pneumonia: an arrhythmogenic disease?” American Journal of Medicine, vol. 126, no. 1, pp. 43–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. A. O. Brown, B. Mann, G. Gao et al., “Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function,” PLoS Pathogens, vol. 10, no. 9, Article ID e100438, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Falcone, A. Russo, R. Cangemi et al., “Lower mortality rate in elderly patients with community‐onset pneumonia on treatment with aspirin,” Journal of the American Heart Association, vol. 4, no. 1, Article ID e001595, 2015. View at Publisher · View at Google Scholar
  57. D. T. Eurich, J. J. Johnstone, J. K. Minhas-Sandhu, T. J. Marrie, and S. R. Majumdar, “Pneumococcal vaccination and risk of acute coronary syndromes in patients with pneumonia: population-based cohort study,” Heart, vol. 98, no. 14, pp. 1072–1077, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. T. W. Perry, M. J. V. Pugh, G. W. Waterer et al., “Incidence of cardiovascular events after hospital admission for pneumonia,” American Journal of Medicine, vol. 124, no. 3, pp. 244–251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Sato, A. Kuriyama, T. Takada, M. Nasu, and S. K. Luthe, “Prevalence and risk factors of sepsis-induced cardiomyopathy. A retrospective cohort study,” Medicine, vol. 95, no. 39, Article ID e5031, 2016. View at Publisher · View at Google Scholar
  60. S. Shahul, G. Gulati, M. R. Hacker et al., “Detection of myocardial dysfunction in septic shock: a speckle-tracking echocardiography study,” Anesthesia and Analgesia, vol. 121, no. 6, pp. 1547–1554, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. F. Sanfilippo, C. Corredor, N. Fletcher et al., “Diastolic dysfunction and mortality in septic patients: a systematic review and meta-analysis,” Intensive Care Medicine, vol. 41, no. 6, pp. 1004–1013, 2015. View at Publisher · View at Google Scholar
  62. A. R. Golden, H. J. Adam, and G. G. Zhanel, “Invasive Streptococcus pneumoniae in Canada, 2011–2014: characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F,” Vaccine, vol. 34, no. 23, pp. 2527–2530, 2016. View at Publisher · View at Google Scholar · View at Scopus
  63. W. W. Williams, P.-J. Lu, A. O'Halloran et al., “Vaccination coverage among adults, excluding influenza vaccination—United States, 2013,” Morbidity and Mortality Weekly Report, vol. 64, no. 4, pp. 95–102, 2015. View at Google Scholar · View at Scopus